Storia in 2 fonti

Alkem Laboratories shares decline over 1% after ₹930 crore promoter stake sale

Alkem Laboratories shares drop over 1% after ₹930 crore promoter stake sale, with trading volatility observed throughout the session.

Raccontata da

economictimes.indiatimes.com

thehindubusinessline.com

Confronto fonti

2 prospettive sulla stessa storia

AI · summaries

thehindubusinessline.comStai leggendo18 h fa

Alkem Laboratories shares decline over 1% after ₹930 crore promoter stake sale

Alkem promoters sold 1.5% stake (₹930 crore) to institutional investors, reducing control to 49.71% and triggering founder Jayanti Sinha's exit. The stake sale signals ownership transition in a large-cap pharma play, with MNCs and domestic funds gaining foothold.

originale

economictimes.indiatimes.com19 h fa

Alkem Labs shares in focus as Goldman, Morgan Stanley, others purchase stake in Rs 930-crore block deal

Alkem Laboratories launched semaglutide pre-filled syringes (India first) at Rs 350, securing DCGI approval for diabetes and obesity treatment. A Rs 930-crore institutional block deal led by ICICI Prudential and Goldman Sachs signals sustained investor confidence in established pharma amid volatility.

Timeline cronologica

martedì 2 giugno 2026·economictimes.indiatimes.com
Alkem Labs sees Rs 930 crore block deal as promoter family entities pare stake; Goldman, Morgan Stanley among key buyers
Alkem Laboratories shares experienced significant block deals totaling Rs 930 crore. Promoter family entities divested shares to a group of domestic mutual funds and foreign…
martedì 2 giugno 2026·thehindubusinessline.com
Alkem Laboratories promoters sell 1.5% stake for Rs 930 crore, holding falls below 50%

Alkem Laboratories shares decline over 1% after ₹930 crore promoter stake sale

Alkem Labs shares in focus as Goldman, Morgan Stanley, others purchase stake in Rs 930-crore block deal

Timeline cronologica

Alkem Labs sees Rs 930 crore block deal as promoter family entities pare stake; Goldman, Morgan Stanley among key buyers

Alkem Laboratories promoters sell 1.5% stake for Rs 930 crore, holding falls below 50%

Stocks in news: Alkem Labs, Vedanta, Canara Bank, NHPC, Adani Ports

Alkem Labs shares in focus as Goldman, Morgan Stanley, others purchase stake in Rs 930-crore block deal

Alkem Laboratories shares decline over 1% after ₹930 crore promoter stake sale